Subtle memory decline linked to Alzheimer’s disease markers
Over three years, 10% of 350 adults without cognitive impairment showed subtle memory decline, linked to higher Alzheimer’s markers than in those with stable memory.
Limit: The cohort was enriched for Alzheimer's risk factors, limiting how broadly the findings apply
Stake: Roche funded the study; authors work for it and hold shares in it. Authors work for Roche Diagnostics International. Authors also declare ties to 1 more company.
Edited by Boris Djordjevic · AgingResearch.News
A prospective observational study followed 350 adults without cognitive impairment, with a mean age of 61; 60% were female. Researchers assessed memory twice over three years and analyzed blood, spinal fluid and brain scans. They identified subtle decline using changes across several memory tests, rather than reported memory complaints.
The decline affected 10% of participants. Compared with participants whose memory remained stable, those with subtle decline had higher levels of biological markers of Alzheimer’s disease, nerve-cell damage and inflammation. Brain scans also linked the decline to greater buildup of amyloid and tau, proteins that accumulate in Alzheimer’s disease.
Why it matters
The authors called for standardized ways to classify early cognitive changes to improve detection and assessment of risk in aging and Alzheimer’s disease before cognitive impairment.
Caveats
This observational study identified associations, not cause and effect. The cohort was enriched for Alzheimer’s risk factors and excluded people with cognitive impairment or major illnesses, limiting how broadly the findings apply.
The paper
Pasqual Maragall Foundation; Instituto de Salud Carlos III
The Journal of Prevention of Alzheimer's Disease, Jun 8, 2026, Open access
Comments
Be the first to comment.